Epigenetic modulation of BRCA1 and BRCA2 gene expression by equol in breast cancer cell lines

British Journal of Nutrition

Volumn 108, Issue 7, 2012, Pages 1187-1193

  Bosviel, Rémy ^a,b   Durif, Julie ^a,b   Déchelotte, Pierre ^b,c   Bignon, Yves Jean ^a,b   Bernard Gallon, Dominique ^a,b  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Breast cancer; Breast cancer susceptibility genes 1 and 2; Equol

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EQUOL;

ALLELE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER SUSCEPTIBILITY; CELL NUCLEUS; CONTROLLED STUDY; CPG ISLAND; CYTOPLASM; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ALLELES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CPG ISLANDS; CYTOPLASM; DNA METHYLATION; EPIGENESIS, GENETIC; EQUOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; PHYTOESTROGENS; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; UP-REGULATION;

EID: 84869444019     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451100657X     Document Type: Article

References (59)

1. Marrian GF & Haslewood GA (1932) Equol, a new inactive phenol isolated from the ketohydroxyoestrin fraction of mares' urine. Biochem J 26, 1227-1232.
2. Axelson M, Kirk DN, Farrant RD, et al. (1982) The identification of the weak oestrogen equol [7-hydroxy-3-(40-hydroxyphenyl)chroman] in human urine. Biochem J 201, 353-357. (Pubitemid 12160165)
3. Setchell KD, Borriello SP, Hulme P, et al. (1984) Nonsteroidal estrogens of dietary origin: possible roles in hormonedependent disease. Am J Clin Nutr 40, 569-578. (Pubitemid 14035518)
4. Setchell KD & Clerici C (2010) Equol: history, chemistry, and formation. J Nutr 140, 1355S-1362S.
5. Setchell KD & Cole SJ (2006) Method of defining equolproducer status and its frequency among vegetarians. J Nutr 136, 2188-2193. (Pubitemid 44156823)
6. Setchell KD, Brzezinski A, Brown NM, et al. (2005) Pharmacokinetics of a slow-release formulation of soybean isoflavones in healthy postmenopausal women. J Agric Food Chem 53, 1938-1944. (Pubitemid 40395758)
7. Jemal A, Bray F, Center MM, et al. (2011) Global cancer statistics. CA Cancer J Clin 61, 69-90.
8. Kuiper GG, Carlsson B, Grandien K, et al. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863-870. (Pubitemid 27089735)
9. Kuiper GG, Lemmen JG, Carlsson B, et al. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263. (Pubitemid 28513713)
10. Pfitscher A, Reiter E & Jungbauer A (2008) Receptor binding and transactivation activities of red clover isoflavones and their metabolites. J Steroid Biochem Mol Biol 112, 87-94.
11. Takeuchi S, Takahashi T, Sawada Y, et al. (2009) Comparative study on the nuclear hormone receptor activity of various phytochemicals and their metabolites by reporter gene assays using Chinese hamster ovary cells. Biol Pharm Bull 32, 195-202.
12. Muthyala RS, Ju YH, Sheng S, et al. (2004) Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R-and Ss-equols and their differing binding and biological activity through estrogen receptors aslpha and beta. Bioorg Med Chem 12, 1559-1567. (Pubitemid 38304880)
13. Satih S, Rabiau N, Bignon YJ, et al. (2008) Soy phytoestrogens and breast cancer chemoprevention: molecular mechanisms. Curr Nutr Food Sci 4, 259-264.
14. Fang MZ, Jin Z, Wang Y, et al. (2005) Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Int J Oncol 26, 615-622.
15. Das PM & Singal R (2004) DNA methylation and cancer. J Clin Oncol 22, 4632-4642. (Pubitemid 41185132)
16. Guha N, Kwan ML, Quesenberry CP, et al. (2009) Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat 118, 395-405.
17. Korde LA, Wu AH, Fears T, et al. (2009) Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev 18, 1050-1059.
18. Lyn-Cook BD, Blann E, Payne PW, et al. (1995) Methylation profile and amplification of proto-oncogenes in rat pancreas induced with phytoestrogens. Proc Soc Exp Biol Med 208, 116-119.
19. Wooster R & Weber BL (2003) Breast and ovarian cancer. N Engl J Med 348, 2339-2347. (Pubitemid 36638109)
20. Cable PL, Wilson CA, Calzone FJ, et al. (2003) Novel consensus DNA-binding sequence for BRCA1 protein complexes. Mol Carcinog 38, 85-96. (Pubitemid 37255144)
21. Jhanwar-Uniyal M (2003) BRCA1 in cancer, cell cycle and genomic stability. Front Biosci 8, s1107-s1117. (Pubitemid 38925373)
22. Kerr P & Ashworth A (2001) New complexities for BRCA1 and BRCA2. Curr Biol 11, R668-R676. (Pubitemid 32774078)
23. Vidarsson H, Mikaelsdottir EK, Rafnar T, et al. (2002) BRCA1 and BRCA2 bind Stat5a and suppress its transcriptional activity. FEBS Lett 532, 247-252. (Pubitemid 35375898)
24. Lambie H, Miremadi A, Pinder SE, et al. (2003) Prognostic significance of BRCA1 expression in sporadic breast carcinomas. J Pathol 200, 207-213. (Pubitemid 36748029)
25. Lerebours F & Lidereau R (2002) Molecular alterations in sporadic breast cancer. Crit Rev Oncol Hematol 44, 121-141. (Pubitemid 36159042)
26. Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171-182. (Pubitemid 34161138)
27. Rice JC, Ozcelik H, Maxeiner P, et al. (2000) Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21, 1761-1765.
28. Matros E, Wang ZC, Lodeiro G, et al. (2005) BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res Treat 91, 179-186. (Pubitemid 40684930)
29. Tapia T, Smalley SV, Kohen P, et al. (2008) Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors. Epigenetics 3, 157-163.
30. Cucer N, Taheri S, Ok E, et al. (2008) Methylation status of CpG islands at sites (59 to \+96 in exon 1 of the BRCA2 gene varies in mammary tissue among women with sporadic breast cancer. J Genet 87, 155-158.
31. Day JK, Bauer AM, DesBordes C, et al. (2002) Genistein alters methylation patterns in mice. J Nutr 132, 2419S-2423S. (Pubitemid 34848119)
32. Dolinoy DC, Weidman JR, Waterland RA, et al. (2006) Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114, 567-572.
33. Fang M, Chen D & Yang CS (2007) Dietary polyphenols may affect DNA methylation. J Nutr 137, 223S-228S. (Pubitemid 46052885)
34. King-Batoon A, Leszczynska JM & Klein CB (2008) Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen 49, 36-45. (Pubitemid 351293011)
35. Majid S, Dar AA, Ahmad AE, et al. (2009) BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 30, 662-670.
36. Cailleau R, Young R, Olive M, et al. (1974) Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53, 661-674.
37. Soule HD, Vazguez J, Long A, et al. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51, 1409-1416.
38. Soule HD, Maloney TM, Wolman SR, et al. (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50, 6075-6086. (Pubitemid 20331424)
39. Vissac-Sabatier C, Bignon YJ & Bernard-Gallon DJ (2003) Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines. Nutr Cancer 45, 247-255. (Pubitemid 37022799)
40. Frommer M, McDonald LE, Millar DS, et al. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89, 1827-1831.
41. Zeschnigk M, Bohringer S, Price EA, et al. (2004) A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus. Nucleic Acids Res 32, e125.
42. Bosviel R, Michard E, Lavediaux G, et al. (2011) Peripheral blood DNA methylation detected in the BRCA1 or BRCA2 promoter for sporadic ovarian cancer patients and controls. Clin Chim Acta 412, 1472-1475.
43. Choi EJ & Kim T (2008) Equol induced apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 but not MCF-7 cells. Mol Med Report 1, 239-244.
44. Bertwistle D & Ashworth A (1998) Functions of the BRCA1 and BRCA2 genes. Curr Opin Genet Dev 8, 14-20.
45. Mathey J, Lamothe V, Coxam V, et al. (2006) Concentrations of isoflavones in plasma and urine of post-menopausal women chronically ingesting high quantities of soy isoflavones. J Pharm Biomed Anal 41, 957-965.
46. Bennetau-Pelissero C, Arnal-Schnebelen B, Lamothe V, et al. (2003) ELISA as a new method to measure genistein and daidzein in food and human fluids. Food Chem 82, 645-658. (Pubitemid 36849612)
47. Jawaid K, Crane SR, Nowers JL, et al. (2010) Long-term genistein treatment of MCF-7 cells decreases acetylated histone 3 expression and alters growth responses to mitogens and histone deacetylase inhibitors. J Steroid Biochem Mol Biol 120, 164-171.
48. Kikuno N, Shiina H, Urakami S, et al. (2008) Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 123, 552-560. (Pubitemid 351898412)
49. Majid S, Dar AA, Shahryari V, et al. (2010) Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer 116, 66-76.
50. Majid S, Kikuno N, Nelles J, et al. (2008) Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res 68, 2736-2744. (Pubitemid 351556271)
51. Hong T, Nakagawa T, Pan W, et al. (2004) Isoflavones stimulate estrogen receptor-mediated core histone acetylation. Biochem Biophys Res Commun 317, 259-264. (Pubitemid 38401993)
52. Berner C, Aumuller E, Gnauck A, et al. (2010) Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds. Ann Nutr Metab 57, 183-189.
53. Guerrero-Bosagna CM, Sabat P, Valdovinos FS, et al. (2008) Epigenetic and phenotypic changes result from a continuous pre and post natal dietary exposure to phytoestrogens in an experimental population of mice. BMC Physiol 8, 17.
54. Qin W, Zhu W, Shi H, et al. (2009) Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. Nutr Cancer 61, 238-244.
55. Tang WY, Newbold R, Mardilovich K, et al. (2008) Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 149, 5922-5931.
56. Vanhees K, Coort S, Ruijters EJ, et al. (2011) Epigenetics: prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage. FASEB J 25, 797-807.
57. Vardi A, Bosviel R, Rabiau N, et al. (2010) Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In vivo 24, 393-400.
58. Wang Z & Chen H (2010) Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116. Anticancer Res 30, 4537-4545.
59. Watanabe Y & Maekawa M (2010) Methylation of DNA in cancer. Adv Clin Chem 52, 145-167.